IMCD Expands in South Korea with YCAM Acquisition

IMCD N.V. (GB:0QVU) has released an update.

IMCD N.V. is set to expand its presence in South Korea’s personal care and pharmaceutical markets by acquiring YCAM Corporation’s life science business. This acquisition aligns with IMCD’s strategy to enhance its life science portfolio and strengthen its market position. The deal is expected to finalize in the second quarter of 2025, pending regulatory approvals.

For further insights into GB:0QVU stock, check out TipRanks’ Stock Analysis page.